Advertisement

Topics

EGeen International Corporation Company Profile

21:50 EST 18th November 2017 | BioPortfolio

Kalev Kask completed his graduate degree with Prof. Tamas Bartfai at Stockholm University and post-doctoral training with Prof. Peter Seeburg at the Max-Planck Institute for Medical Research in Heidelberg. He then joined the neurogenomics company AGY Therapeutics of South San Francisco as a senior scientist, followed by research at Stanford University and advisory work with Asper Biotech and Toshiba prior to founding EGeen. Dr. Kask has authored numerous scientific publications and has patented genomics derived drug and diagnostic targets.

Location

1949 Landings Drive
Mountain View
California
94043
United States of America

Contact

Phone: 1 650 967 5010
Fax: 1 650 967 5014
Email: egeeninc@egeeninc.com


News Articles [119 Associated News Articles listed on BioPortfolio]

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation

IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation

IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation

IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based r...

ICC International Cannabis Corporation Provides Cannabinoid Extract Business Segment Update

Highlights:

International Business Machines Corp - Doc re 10-Q

Company INTERNATIONAL BUSINESS MACHINES CORPORATION TIDM IBM Headline Notification of filing of document The Corporation's quarterly report on Form 10-Q date 25/07/2017 was filed with the United S...

International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease

CARLSBAD, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies...

International Stem Cell Corporation Announces Operating Results for the Three and Nine-Months ended September 30, 2017

CARLSBAD, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical...

International Stem Cell Corporation to Move Forward with Traumatic Brain Injury Phase II Clinical Trial

CARLSBAD, Calif., Sept. 20, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage ...

PubMed Articles [688 Associated PubMed Articles listed on BioPortfolio]

Simplified Method for Local Correction of System International Normalized Ratio.

International normalized ratio (INR) derivation is dependent on the international sensitivity index (ISI) of thromboplastin. It varies with instrument and reagents used.

Gender and international clinician educators.

To describe gender differences of international clinician educators (CEs) and leaders, and CEs' perceptions by gender of preparation, roles, rewards and factors affecting job satisfaction and retentio...

Why You Should Become an International Academy of Compounding Pharmacists Member.

The International Academy of Compounding Pharmacists Introduces a New President.

International Academy of Compounding Pharmacists Legislative/Regulatory Update.

Clinical Trials [816 Associated Clinical Trials listed on BioPortfolio]

International AGD Database; Determinants of AGD and Establishment of Normative Data

Aim: To collate data on Anogenital Distance (AGD) from several population studies to build an international database for Anogenital Distance (AGD) Primary objective: To build a database p...

International Study on NoSocomial Pneumonia in Intensive CaRE

The International study on NoSocomial Pneumonia in Intensive CaRE (PneumoINSPIRE) is a prospective, international, multicentre, observational, cohort study. The study aims to provide up-to...

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

LCH III is an international, multicentric, prospective clinical study comprised of: - a randomized clinical trial for multisystem "RISK" patients and - a randomized clinical trial ...

Valiant Evo International Clinical Trial

The purpose of the Valiant Evo International Clinical Trial is to demonstrate the safety and effectiveness of the Valiant Evo Thoracic Stent Graft System in subjects with a descending thor...

Companies [1412 Associated Companies listed on BioPortfolio]

EGeen International Corporation

Kalev Kask completed his graduate degree with Prof. Tamas Bartfai at Stockholm University and post-doctoral training with Prof. Peter Seeburg at the Max-Planck Institute for Medical Research in Heidel...

Service Corporation International

Service Corporation International (NYSE: SCI), headquartered in Houston, Texas, is North America’s leading provider of deathcare products and services. At June 30, 2010, we o...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

Celgene International Sàrl

Celgene International Sàrl, located in Boudry, in the Canton of Neuchâtel, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. C...

More Information about "EGeen International Corporation" on BioPortfolio

We have published hundreds of EGeen International Corporation news stories on BioPortfolio along with dozens of EGeen International Corporation Clinical Trials and PubMed Articles about EGeen International Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EGeen International Corporation Companies in our database. You can also find out about relevant EGeen International Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record